Addition of blinatumomab to chemotherapy improves survival in children - Medizinonline

Acute lymphoblastic leukemia (ALL) is the most common childhood cancer. Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) with standard risk (SR) have a high survival rate when treated with conventional chemotherapy. The chances of survival deteriorate if a relapse occurs.

Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich
Jetzt beitreten

Already a member? Log in here

Autoren

Birke Dikken

Publikation

InFo ONKOLOGIE & HÄMATOLOGIE

Related Topics

Previous Article

Advanced breast cancer

Next-generation SERD therapy with promising results

From symptom to diagnosis

Abdominal pain – chronic pancreatitis

You May Also Like

4 min

Preclinical Study on a Special Ginkgo biloba Extract

What role do proanthocyanidins play?

6 min

Myasthenia gravis: immunomodulatory therapies for long-term treatment

Expanded Possibilities Thanks to Innovative Classes of Active Ingredients

7 min

Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

10 min

Interstitial Lung Diseases

Update on Idiopathic Pulmonary Fibrosis

7 min

Ischemic stroke: Are smaller or larger brain arteries affected?

Recent study findings on intravenous lysis therapy with fibrinolytic agents

7 min

Interview

“On par with the gold standards for trauma”

5 min

Psychology: Emotional Freedom Techniques (EFT)

Emotional Healing Through Tapping

5 min

Systemic Lupus (SLE): What Does the Diagnosis and Treatment Toolbox Have to Offer?

Treat-to-Target – Consensus Recommendations for GC Tapering and the Use of DMARDs

Input your search keywords and press Enter.